CERS2 and breast cancer: The overexpression of LASS2 in MCF-7/ADR breast cancer cells increased the effect of several chemotherapeutic agents. LASS2 inhibited the function of V-ATPase. More DOX entered the cells and stayed in the nuclei of cells, inducing increased rates of apoptosis.